Spots Global Cancer Trial Database for postoperative chemotherapy
Every month we try and update this database with for postoperative chemotherapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Combination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery | NCT01189227 | Colorectal Canc... Metastatic Canc... | Postoperative c... Perioperative c... | 18 Years - | NSABP Foundation Inc | |
Treatment Strategy for Stage IV Gastric Cancer With Positive Peritoneal Cytology as the Only Non-curable Factor | NCT02969122 | Stomach Neoplas... | standard gastre... hyperthermic in... Extensive intra... Preoperative ch... Postoperative c... | - | Peking University | |
Combination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery | NCT01189227 | Colorectal Canc... Metastatic Canc... | Postoperative c... Perioperative c... | 18 Years - | NSABP Foundation Inc | |
Efficacy of HIPEC in the Treatment of Advanced-Stage Epithelial Ovarian Cancer After Cytoreductive Surgery | NCT03373058 | Epithelial Ovar... Fallopian Tube ... Primary Periton... | Hyperthermic In... cytoreductive s... adjuvant chemot... | 18 Years - 70 Years | Affiliated Cancer Hospital & Institute of Guangzhou Medical University | |
Treatment Strategy for Stage IV Gastric Cancer With Positive Peritoneal Cytology as the Only Non-curable Factor | NCT02969122 | Stomach Neoplas... | standard gastre... hyperthermic in... Extensive intra... Preoperative ch... Postoperative c... | - | Peking University | |
Irinotecan-based Triplet (FOLFOXIRI) as Perioperative Treatment in Resectable Gastric and Gastroesophageal Junction Adenocarcinoma. | NCT03773367 | Resectable Gast... | Fluorouracil Oxaliplatin Irinotecan | 18 Years - | Lund University Hospital | |
Study of Oral Metronidazole on Postoperative Chemotherapy in Colorectal Cancer | NCT04264676 | Colorectal Canc... Colorectal Canc... | Metronidazole O... Placebo oral ta... | 18 Years - 75 Years | Shanghai Jiao Tong University School of Medicine | |
Perioperative Chemotherapy VS Postoperative Chemotherapy for the Treatment of Colon Cancer With Resectable Liver Metastasis | NCT02912052 | Colon Cancer | Peri-operative ... postoperative c... | 18 Years - 80 Years | The First Affiliated Hospital with Nanjing Medical University | |
Preoperative Systemic Therapy for Colorectal Cancer Peritoneal Metastases | NCT05353582 | Colorectal Neop... Colorectal Canc... Colorectal Canc... Peritoneal Meta... Peritoneal Canc... Peritoneal Neop... Chemotherapy Ef... Cytoreductive S... Hyperthermic In... | Preoperative sy... CRS+HIPEC Postoperative c... Postoperative c... | 18 Years - 75 Years | Sun Yat-sen University | |
Irinotecan-based Triplet (FOLFOXIRI) as Perioperative Treatment in Resectable Gastric and Gastroesophageal Junction Adenocarcinoma. | NCT03773367 | Resectable Gast... | Fluorouracil Oxaliplatin Irinotecan | 18 Years - | Lund University Hospital | |
Efficacy of HIPEC as NACT and Postoperative Chemotherapy in the Treatment of Advanced-Stage Epithelial Ovarian Cancer | NCT03180177 | Epithelial Ovar... Fallopian Tube ... Primary Periton... | Hyperthermic In... Interval debulk... neoadjuvant che... adjuvant chemot... | 18 Years - 70 Years | Affiliated Cancer Hospital & Institute of Guangzhou Medical University | |
The Role of Postoperative Cycles in the Perioperative Chemotherapy for Gastric Cancer | NCT01787539 | Gastric Cancer | Postoperative C... | 18 Years - | Medical University of Lublin | |
Study Evaluating the Efficacy of the myDIET Software Tool in the Nutritional Management of Patients With Localized and Resectable Gastric or Esogastric Junction Cancer. | NCT06385691 | Gastric Cancer Oesogastric Jun... | myDIET software... | 18 Years - | Centre Leon Berard | |
Study of Preoperative Chemotherapy for Early Triple Negative or HER2-positive Operable Breast Cancer | NCT02934828 | Breast Cancer | Neoadjuvant Che... postoperative c... | 18 Years - 70 Years | ChineseAMS | |
Efficacy of HIPEC in the Treatment of Advanced-Stage Epithelial Ovarian Cancer After Cytoreductive Surgery | NCT03373058 | Epithelial Ovar... Fallopian Tube ... Primary Periton... | Hyperthermic In... cytoreductive s... adjuvant chemot... | 18 Years - 70 Years | Affiliated Cancer Hospital & Institute of Guangzhou Medical University | |
Neoadjuvant Chemotherapy for the Treatment of Resectable Locally Advanced Colon Cancer | NCT02882269 | Colon Cancer | Postoperative c... Neoadjuvant che... | 18 Years - 80 Years | The First Affiliated Hospital with Nanjing Medical University |